Roche receives an emergency use authorization This link will open in a new window from the US FDA for its diagnostic test against SARS-CoV-2, known as a PCR test.
66 days after the sharing of the SARS-CoV-2 sequence, the first participant of a Phase 1 clinical trial This link will open in a new window study is dosed with Moderna's COVID-19 vaccine candidate.
Pfizer and BioNTech join forces to develop an mRNA COVID-19 vaccine This link will open in a new window, based on a 2018 agreement to develop an mRNA-based influenza vaccine.
The WHO announces its first Solidarity trial This link will open in a new window, an international study examining the efficacy of four promising therapeutics against COVID-19 This link will open in a new window. Gilead and AbbVie donate courses of their treatments.